Cargando…
Genomic identification of sarcoma radiosensitivity and the clinical implications for radiation dose personalization
BACKGROUND: Soft-tissue sarcomas (STS) are heterogeneous with variable response to radiation therapy (RT). Utilizing the radiosensitivity index (RSI) we estimated the radiobiologic ratio of lethal to sublethal damage (α/β), genomic-adjusted radiation dose(GARD), and in-turn a biological effective ra...
Autores principales: | Yang, George, Yuan, Zhigang, Ahmed, Kamran, Welsh, Eric A., Fulp, William J., Gonzalez, Ricardo J., Mullinax, John E., Letson, Douglas, Bui, Marilyn, Harrison, Louis B., Scott, Jacob G., Torres-Roca, Javier F., Naghavi, Arash O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274330/ https://www.ncbi.nlm.nih.gov/pubmed/34246048 http://dx.doi.org/10.1016/j.tranon.2021.101165 |
Ejemplares similares
-
The radiosensitivity index predicts for overall survival in glioblastoma
por: Ahmed, Kamran A., et al.
Publicado: (2015) -
Staged reconstruction brachytherapy has lower overall cost in recurrent soft-tissue sarcoma
por: Naghavi, Arash O., et al.
Publicado: (2017) -
Effect of Favorable Pathologic Response After Neoadjuvant Radiation Therapy Alone in Soft-tissue Sarcoma
por: Palm, Russell F., et al.
Publicado: (2022) -
The Future of Radiation Oncology in Soft Tissue Sarcoma
por: Naghavi, Arash O., et al.
Publicado: (2018) -
Long-Term Clinical Responses of Neoadjuvant Dendritic Cell Infusions and Radiation in Soft Tissue Sarcoma
por: Raj, Shailaja, et al.
Publicado: (2015)